FEDERALhearing transcript

High Impact

Senate Hearing on Alzheimer's Disease Prevention and Care

Original title: THE ARC OF ALZHEIMER'S: FROM PREVENTING COGNITIVE DECLINE IN AMERICANS TO ASSURING QUALITY CARE FOR THOSE LIVING WITH THE DISEASE

January 1, 2017

Alzheimer's disease healthcare aging Medicare Medicaid medical research

Track this bill to get notified when it advances a stage. One tap to stop, anytime.

The Frame

What this does

The hearing highlights the national economic and personal impact of Alzheimer's, which currently affects 5.5 million Americans and costs the U.S. $259 billion annually, with projections suggesting 14 million cases by 2050.

Who is mentioned in the record

Potentially affected actors named in the source documents. Mention is not a position.

Alzheimer's patients

Individuals living with the disease face daily challenges and require ongoing care.

Family caregivers

Family members provide significant personal care and support for those living with the disease.

Medicare and Medicaid programs

These government programs bear $175 billion of the annual costs associated with Alzheimer's care.

What changed

Last recorded activity January 1, 2017.

What's next

Next step not available in the current record.

Summary

The U.S. Senate Special Committee on Aging held a hearing on March 29, 2017, to discuss the growing impact of Alzheimer's disease on Americans. The committee examined the current state of research, the economic burden on the healthcare system, and the challenges faced by patients and caregivers.

Key Facts

Approximately 5.5 million Americans are currently living with Alzheimer's disease.
The U.S. spends more than $259 billion per year on Alzheimer's care.
Medicare and Medicaid programs account for $175 billion of the annual Alzheimer's-related costs.
Projections indicate that 14 million Americans could be living with Alzheimer's by 2050.
There is currently no effective means of prevention, treatment, or cure for Alzheimer's disease.
The hearing took place on March 29, 2017, in the Dirksen Senate Office Building.
The committee heard testimony from medical experts, a journalist, and a family caregiver.

Frequently Asked Questions

How many people in the U.S. have Alzheimer's?

Approximately 5.5 million Americans are currently living with the disease.

What is the annual economic cost of Alzheimer's in the U.S.?

The U.S. spends more than $259 billion per year, with $175 billion of that cost falling on Medicare and Medicaid.

Why It Matters

News Coverage

No news coverage found yet. Articles are indexed twice daily.

Discoveries

Patterns POLISCOPE noticed across the record. These are observations to investigate, not conclusions.

policy shift90% confidence

Focus on Early Detection

The hearing emphasized the importance of early testing and diagnosis as a strategy for managing the disease's progression.

Bob O'Keefe

Connected Entities

organizationSpecial Committee on Aging“Senate committee conducting the hearing”Map →

personPhyllis Gallagher“Witness, Family Caregiver”Map →

personMaria Shriver“Witness, Founder of The Women's Alzheimer's Movement”Map →

personRobert P. Casey, Jr.“Ranking Member of the Special Committee on Aging”Map →

personKristine Yaffe“Witness, Professor at UCSF”Map →

personSusan M. Collins“Chairman of the Special Committee on Aging”Map →

personChristopher M. Callahan“Witness, Director of Indiana University Center for Aging Research”Map →

Sources

Open source document

www.govinfo.gov

Analysis Score

0–100

Significance80
How much this matters to a regular citizen
Controversy10
Intensity of disagreement among stakeholders
Entertainment15
Compellingness for a non-policy-wonk reader
Buzz20
Current news / social attention level

Publisher tools